Data as of:
Price 02-03-26 16:00 ET,
Balance Sheet 2025-09-30,
Income Statement 2025-09-30,
Cash Flow 2025-09-30
Indicators
Dividend indicators
Value
Date
Pays Dividend
No
2-1-2026
Last Dividend Date
3-31-19
Income indicators
Value
Date
EBITDA Positive
No
2-1-2026
Net Income Positive
No
2-1-2026
Avg CA Burn (Annual %)
-37.75%
2-1-2026
Avg CA Burn (Quarterly %)
-8.88%
2-1-2026
Shares Outstanding Changes
Date
Shares Outstanding
Delta
2025-12-02
18,293,776
+2,589,154
2025-09-23
15,704,622
+22
2025-08-22
15,704,600
+102,300
Short Interest Changes
Latest short interest:
1,731,696 shares
(9.61% of float)
| Days to cover: 4.58
Date
Short Interest
Delta
Δ %
2026-02-03
1,731,696 shares
+0
+0.00%
2026-02-02
1,731,696 shares
+0
+0.00%
2026-01-30
1,731,696 shares
None
—
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
Date
Volume
Shares Outstanding
Volume / Shares
Price
No interesting volume events
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.